Avricore Health INC. (AVCRF) — 20-F Filings
All 20-F filings from Avricore Health INC.. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (2)
-
Avricore Health's Net Loss Widens 59% Amidst Capital Raises
— Jun 16, 2025 Risk: high
Avricore Health Inc. reported a net loss of $1,677,000 for the fiscal year ended December 31, 2024, a significant increase from the net loss of $1,053,000 in 20 -
Avricore Health Inc. Files 20-F for FY2023
— Jun 12, 2024 Risk: medium
Avricore Health Inc. filed its 20-F form for the fiscal year ending December 31, 2023. The company, formerly known as Vanc Pharmaceuticals Inc., NUVA Pharmaceut
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX